MA29000B1 - Composes d'acide 4-methoxymethyl-pyrrolidine-2-carboxylique et leurs derives utilises comme inhibiteurs du virus de l'hepatite c - Google Patents

Composes d'acide 4-methoxymethyl-pyrrolidine-2-carboxylique et leurs derives utilises comme inhibiteurs du virus de l'hepatite c

Info

Publication number
MA29000B1
MA29000B1 MA29846A MA29846A MA29000B1 MA 29000 B1 MA29000 B1 MA 29000B1 MA 29846 A MA29846 A MA 29846A MA 29846 A MA29846 A MA 29846A MA 29000 B1 MA29000 B1 MA 29000B1
Authority
MA
Morocco
Prior art keywords
methoxymethyl
pyrrolidine
hepatitis
virus
inhibitors
Prior art date
Application number
MA29846A
Other languages
English (en)
Inventor
Rossella Guidetti
David Haigh
Charles David Hartley
Peter David Howes
Fabrizio Nerozzi
Stephen Allan Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33485164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29000(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA29000B1 publication Critical patent/MA29000B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA29846A 2004-10-25 2007-04-25 Composes d'acide 4-methoxymethyl-pyrrolidine-2-carboxylique et leurs derives utilises comme inhibiteurs du virus de l'hepatite c MA29000B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0423673.3A GB0423673D0 (en) 2004-10-25 2004-10-25 Compounds

Publications (1)

Publication Number Publication Date
MA29000B1 true MA29000B1 (fr) 2007-11-01

Family

ID=33485164

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29846A MA29000B1 (fr) 2004-10-25 2007-04-25 Composes d'acide 4-methoxymethyl-pyrrolidine-2-carboxylique et leurs derives utilises comme inhibiteurs du virus de l'hepatite c

Country Status (18)

Country Link
US (1) US20070270475A1 (fr)
EP (1) EP1805172A1 (fr)
JP (1) JP2008517968A (fr)
KR (1) KR20070072614A (fr)
CN (1) CN101087785A (fr)
AR (1) AR051340A1 (fr)
AU (1) AU2005298849A1 (fr)
BR (1) BRPI0517023A (fr)
CA (1) CA2585170A1 (fr)
GB (1) GB0423673D0 (fr)
IL (1) IL182583A0 (fr)
MA (1) MA29000B1 (fr)
MX (1) MX2007004914A (fr)
NO (1) NO20072547L (fr)
PE (1) PE20060602A1 (fr)
RU (1) RU2007119390A (fr)
TW (1) TW200630365A (fr)
WO (1) WO2006045613A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
MX2009011930A (es) 2007-05-04 2009-11-18 Vertex Pharma Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
UA103195C2 (uk) 2008-08-11 2013-09-25 Глаксосмитклайн Ллк Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
BRPI0917458A2 (pt) 2008-08-11 2015-12-01 Glaxosmithkline Llc composto, método de tratamento de doenças e condições, composição farmacêutica, método para tratar ou prevenir doença, e, uso de um composto
CN102176911B (zh) 2008-08-11 2014-12-10 葛兰素史密丝克莱恩有限责任公司 新的腺嘌呤衍生物
US8575340B2 (en) 2010-02-10 2013-11-05 Glaxosmithkline Llc Purine derivatives and their pharmaceutical uses
RS53745B1 (sr) 2010-02-10 2015-06-30 Glaxosmithkline Llc 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on-maleat
KR20160124157A (ko) 2014-02-20 2016-10-26 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 인간 인터페론의 유도인자로서의 피롤로[3,2]피리미딘 유도체
CA2948071C (fr) 2014-05-07 2022-08-30 Boehringer Ingelheim International Gmbh Contenant, nebuliseur et utilisation
ES2917887T3 (es) 2014-11-13 2022-07-12 Glaxosmithkline Biologicals Sa Derivados de adenina que son útiles en el tratamiento de enfermedades alérgicas u otras afecciones inflamatorias
JP6411676B2 (ja) 2015-12-03 2018-10-24 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｓｔｉｎｇの調節因子としての環状プリンジヌクレオチド
WO2017175156A1 (fr) 2016-04-07 2017-10-12 Glaxosmithkline Intellectual Property Development Limited Amides hétérocycliques utiles en tant que modulateurs de protéine
SG10201900628RA (en) 2016-04-07 2019-02-27 Glaxosmithkline Ip Dev Ltd Heterocyclic amides useful as protein modulators
AU2018344902B2 (en) 2017-10-05 2021-06-03 Glaxosmithkline Intellectual Property Development Limited Modulators of stimulator of interferon genes (STING) useful in treating HIV
US11377440B2 (en) 2017-10-05 2022-07-05 Glaxosmithkline Intellectual Property Development Limited Modulators of stimulator of interferon genes (STING)
GB201807924D0 (en) 2018-05-16 2018-06-27 Ctxt Pty Ltd Compounds
JP2022533390A (ja) 2019-05-16 2022-07-22 スティングセラ インコーポレイテッド オキソアクリジニル酢酸誘導体および使用方法
US20220251079A1 (en) 2019-05-16 2022-08-11 Stingthera, Inc. Benzo[b][1,8]naphthyridine acetic acid derivatives and methods of use
GB201910305D0 (en) 2019-07-18 2019-09-04 Ctxt Pty Ltd Compounds
GB201910304D0 (en) 2019-07-18 2019-09-04 Ctxt Pty Ltd Compounds
WO2021119753A1 (fr) 2019-12-18 2021-06-24 Ctxt Pty Limited Composés
US12274700B1 (en) 2020-10-30 2025-04-15 Accencio LLC Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200418848A (en) * 2002-10-24 2004-10-01 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
CN101087785A (zh) 2007-12-12
AU2005298849A1 (en) 2006-05-04
JP2008517968A (ja) 2008-05-29
US20070270475A1 (en) 2007-11-22
GB0423673D0 (en) 2004-11-24
WO2006045613A1 (fr) 2006-05-04
AR051340A1 (es) 2007-01-03
CA2585170A1 (fr) 2006-05-04
BRPI0517023A (pt) 2008-09-30
KR20070072614A (ko) 2007-07-04
NO20072547L (no) 2007-07-23
MX2007004914A (es) 2007-06-12
TW200630365A (en) 2006-09-01
IL182583A0 (en) 2007-07-24
PE20060602A1 (es) 2006-07-15
EP1805172A1 (fr) 2007-07-11
RU2007119390A (ru) 2008-12-10

Similar Documents

Publication Publication Date Title
EP2097111A4 (fr) Hétérodimères d'acide glutamique
EP2178897A4 (fr) Séquences d'acide nucléique pour l'amplification et la détection de virus respiratoires
IL182583A0 (en) 4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors
EP2096912A4 (fr) Préparations à base de dérivés d'acide 2-hydroxy-5-phénylazobenzoïque et leurs applications
DE60119283D1 (de) Verfahren zur herstellung von 3-hydroxypicolinsäure-derivaten
EP1763531A4 (fr) Analogues peptidiques d'inhibiteurs de l'hepatite c
EP1753708A4 (fr) Noveaux composes activant sirtuine et leurs methodes de preparation
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
MA28818B1 (fr) Nouveaux derives amides d'acide carboxylique heterocyclique
MA28365A1 (fr) Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application comme inhibiteurs de l'enzyme faah
DE602004024402D1 (de) Verfahren zur herstellung von tetrazolderivaten au
EP1584320A4 (fr) Preparation cosmetique contenant des derives d'acide glycerylamine
NO20032822D0 (no) Fremgangsmåte for konsentrering av brukt syre
MA28394B1 (fr) Derives d'heteroaryle pour traitement des virus
MA28804B1 (fr) Formulations d'acide suberoylanilide hydroxamique et leurs procedes de production
EP1591524A4 (fr) Oligoribonucleotide ou acide nucleique peptidique inhibant la fonction du virus de l'hepatite c
EP1771585A4 (fr) Compositions et procedes de detection d'un acide nucleique du virus de l'hepatite a
DE60217414D1 (de) Verfahren zur Herstellung von Alpha-Hydroxycarbonsäure Amiden
DE502004009152D1 (de) Verfahren zur herstellung von derivaten des 4a,5,9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
NO20084860L (no) Stabile farmasøytiske preparater av 2-aza-bisyklo-[3,3,0]-oktan-3-karboksylsyrederivater
IS8232A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
EP1874755A4 (fr) Derives benzothiophene d'acide hydroxamique
DE602005024566D1 (de) Verfahren zur herstellung von 2-amino-5-iodobenzoesäure
DE502005009157D1 (de) Verfahren zur herstellung von alkenylbernsteinsäureanhydriden
EP1829864A4 (fr) Derives d'isoquiline utiles en tant qu'inhibiteurs de la calpaine